cloudfront

Report Detail

Service & SoftwareGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2019-2024

  • RnM2930445
  • |
  • 12 February, 2019
  • |
  • Global
  • |
  • 154 pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2019-2024

Table of Contents

    2019-2024 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size 2014-2024
        • 2.1.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Size CAGR by Region
      • 2.2 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type
        • 2.2.1 Transversion
        • 2.2.2 Transition
      • 2.3 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
        • 2.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Type (2014-2019)
      • 2.4 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application
        • 2.4.1 Diagnostics
        • 2.4.2 Animal
        • 2.4.3 Plant
        • 2.4.4 Research
        • 2.4.5 Others
      • 2.5 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
        • 2.5.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate by Application (2014-2019)

      3 Global Single Nucleotide Polymorphism (SNP) Genotyping by Players

      • 3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Players
        • 3.1.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Players (2017-2019)
        • 3.1.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Market Share by Players (2017-2019)
      • 3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Single Nucleotide Polymorphism (SNP) Genotyping by Regions

      • 4.1 Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions
      • 4.2 Americas Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth
      • 4.3 APAC Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth
      • 4.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth
      • 4.5 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth

      5 Americas

      • 5.1 Americas Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Countries
      • 5.2 Americas Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
      • 5.3 Americas Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Countries
      • 6.2 APAC Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
      • 6.3 APAC Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping by Countries
      • 7.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
      • 7.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping by Countries
      • 8.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
      • 8.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast

      • 10.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast (2019-2024)
      • 10.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast by Regions
        • 10.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast by Type
      • 10.8 Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast by Application

      11 Key Players Analysis

      • 11.1 Illumina
        • 11.1.1 Company Details
        • 11.1.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Illumina News
      • 11.2 Affymetrix
        • 11.2.1 Company Details
        • 11.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Affymetrix News
      • 11.3 Applied Biosystems
        • 11.3.1 Company Details
        • 11.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Applied Biosystems News
      • 11.4 Agilent Technologies
        • 11.4.1 Company Details
        • 11.4.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Agilent Technologies News
      • 11.5 Beckman Coulter
        • 11.5.1 Company Details
        • 11.5.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Beckman Coulter News
      • 11.6 Roche
        • 11.6.1 Company Details
        • 11.6.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Roche News
      • 11.7 Qiagen
        • 11.7.1 Company Details
        • 11.7.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Qiagen News
      • 11.8 Luminex Corporation
        • 11.8.1 Company Details
        • 11.8.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Luminex Corporation News
      • 11.9 Enzo Life Sciences
        • 11.9.1 Company Details
        • 11.9.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Enzo Life Sciences News
      • 11.10 Bio-rad
        • 11.10.1 Company Details
        • 11.10.2 Single Nucleotide Polymorphism (SNP) Genotyping Product Offered
        • 11.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Bio-rad News
      • 11.11 Sequenom
      • 11.12 Ocimum Biosolutions
      • 11.13 GE Healthcare
      • 11.14 GenScript
      • 11.15 Douglas Scientific
      • 11.16 BGI
      • 11.17 Beijing Sunbiotech
      • 11.18 HuaGene Biotech
      • 11.19 Generay Biotech
      • 11.20 Benegene
      • 11.21 Shanghai Biochip
      • 11.22 GENESKY
      • 11.23 HD Biosciences

      12 Research Findings and Conclusion

      Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.
      SNP genotyping is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. In the whole SNP genotyping industry, only a few companies can provide SNP genotyping platform while SNP genotyping service provider are located widely in the world.

      SNP genotyping has various genotyping methods, such as TaqMan probe method, SNaPshot method, .MassArray method, .Illumina BeadXpress, HRM method and so on. Each method has its own characteristics. SNP genotyping will adopt an appropriate method according their customers’ specific demand or wanted results.

      Illumina, Affymetrix and Applied Biosystems are industry leaders. They can provide SNP genotyping platform, reagent and service to their clients. Besides, all of them have authorized companies around the word to use their platform to offer genotyping service to some countries. In fact, in the platform field, the industry is still highly monopolized for the time being.

      We tend to believe that this industry still has a bright future, considering the current gene research. There is also no doubt that there are will be more and more companies to provide innovative SNP genotyping related products and service to customers in the next few years, promoting the industry to develop healthily.

      According to this study, over the next five years the Single Nucleotide Polymorphism (SNP) Genotyping market will register a 21.2% CAGR in terms of revenue, the global market size will reach US$ 24100 million by 2024, from US$ 7620 million in 2019. In particular, this report presents the global revenue market share of key companies in Single Nucleotide Polymorphism (SNP) Genotyping business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Single Nucleotide Polymorphism (SNP) Genotyping market by product type, application, key companies and key regions.

      This study considers the Single Nucleotide Polymorphism (SNP) Genotyping value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Transversion
      Transition
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Diagnostics
      Animal
      Plant
      Research
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Illumina
      Affymetrix
      Applied Biosystems
      Agilent Technologies
      Beckman Coulter
      Roche
      Qiagen
      Luminex Corporation
      Enzo Life Sciences
      Bio-rad
      Sequenom
      Ocimum Biosolutions
      GE Healthcare
      GenScript
      Douglas Scientific
      BGI
      Beijing Sunbiotech
      HuaGene Biotech
      Generay Biotech
      Benegene
      Shanghai Biochip
      GENESKY
      HD Biosciences

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Single Nucleotide Polymorphism (SNP) Genotyping market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Single Nucleotide Polymorphism (SNP) Genotyping market by identifying its various subsegments.
      Focuses on the key global Single Nucleotide Polymorphism (SNP) Genotyping players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Single Nucleotide Polymorphism (SNP) Genotyping with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Single Nucleotide Polymorphism (SNP) Genotyping submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.




      Summary:
      Get latest Market Research Reports on Single Nucleotide Polymorphism (SNP) Genotyping . Industry analysis & Market Report on Single Nucleotide Polymorphism (SNP) Genotyping is a syndicated market report, published as Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Single Nucleotide Polymorphism (SNP) Genotyping market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,457.69
      3,686.54
      4,915.38
      3,367.93
      5,051.90
      6,735.86
      443,372.40
      665,058.60
      886,744.80
      242,707.04
      364,060.57
      485,414.09
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report